In recent years, much attention has been paid to the monomeric GTP-binding protein Rab3. Originally, the attention was attracted by two observations: (i) the expression of Rab3a is not ubiquitous, unlike that of other members of the Rab family, but is restricted to brain and other organs with a regulated secretion, such as the adrenal medulla and the pancreatic islets; and (ii) mutation of SEC4, which shows some homology with Rab3a, inhibits vesicular traffic between the trans-Golgi network and the plasma membrane in yeast. From these observations, it was hypothesized that Rab3a might be involved in regulated exocytosis. This hypothesis was conAbbreviations used: Ach, acetylcholine; GDI, guaninenucleotide-dissociation inhibitor; GAP, GTPase-activating protein; SNAP-25, 25 kDa synaptosomeassociated protein; SNARE, receptor for soluble h'-ethylmaleimide-sensitive fusion protein attachment protein; VAMP, vesicle-associated membrane protein.
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sistent with the proposed role of the Rab proteins in the regulation and the specificity of intracellular membrane traffic [ 1-31. It is now well documented that each member of the Rab family is associated with a defined step of intracellular traffic. Accordingly, Rab proteins are specifically associated with distinct intracellular compartments. Rab3a was found to be associated with synaptic vesicles [4] and secretory granules, such as chromaffin granules [S, 61, and it is also present in a soluble form in the secretory cells, consistent with the cycle originally proposed by Bourne [ 71.
Control of neurotransmitter and hormone secretion by Rab3a
Monomeric GTP-binding proteins have been described as cellular switches oscillating between two conformations corresponding to the GDPand GTP-bound forms. The interaction with various partners regulates this conformational change and allows the integration of multiple signals. Several of these factors are known or postulated, such as GTPase-activating protein (GAP), guanine-nucleotide-release factor and guaninenucleotide-dissociation inhibitor (GDI). The function of others is not yet clearly established, such as Rabphilin-3A, Rabin3 and, in the case of RabS, Rabaptin.
According to this view, changing the equilibrium between the GDP-and the GTP-bound forms of Rab3a should have some effect on the secretory response. The most striking results were obtained with a mutant of human Rab3a, Rab3aQ81L, with a reduced GTPase activity [8] . Introduction of the Q 8 l L mutant in chromaffin cells unambiguously inhibited exocytosis. This result has been obtained in several ways. (i) Transient expression of Rab3aQ81L with the T 7 recombinant vaccinia virus system in pheochromocytoma PC 12 cells blocked exocytosis, as revealed by a reduced appearance on the plasma membrane of an antigen located on the internal face of chromaffin granule membranes [9] . (ii) Co-expression of Rab3aQ81L and growth hormone in primary cultures of bovine chromaffin cells blocked growth hormone secretion, which had been shown to occur through chromaffin granule exocytosis [ 101. (iii) Microinjection of the purified recombinant mutated protein into bovine chromaffin cells inhibited exocytosis, which was monitored by measuring cell membrane capacitance by the patch-clamp technique [9] . More recently, we have extended these observations to the neurons of the buccal ganglion of Apl~vszu (L. Johannes, F. Dousseau, A. Clabecq, J.-P. Henry, F. Darchen and B. Poulain, unpublished work). Recombinant proteins were microinjected into the cell body of identified cholinergic neurons, and the effect on acetylcholine (Ach) release was monitored by recording the electrical response of the post-synaptic neuron. Injection of hu/apRab3aQ81L, a chimaeric protein obtained by replacing the last 24 amino acids of human Rab3a with those of Aplysiu Rab3, resulted in a marked inhibition of neurotransmitter release.
These observations led to the proposal that G T P hydrolysis by Rab3a may be rate limiting in the exocytotic process. This hypothesis is consistent with several other pieces of evidence: (i) Rab3aT36N, a mutant that has a low affinity for G T P and which is thus believed to be mostly in the GDP-bound form, has no effect on exocytosis, either in chromaffin cells [9, 10] or in Aplysia neurons; and (ii) microinjection of mh3a antisense oligonucleotides into chromaffin cells did not block exocytosis. Interestingly enough, the response to repetitive stimuli was even enhanced after antisense treatment ")I. This observation suggests that, in addition to its role in modulating exocytosis, Rab3a might be involved, probably through its partners, in the generation of complex regulatory mechanisms, such as desensitization, response habituation or potentiation.
It should be noted that Rab proteins are generally believed to promote docking or fusion of a transport vesicle with its target membrane. For instance, it has clearly been shown that RabS regulates positively endocytosis and homotypic fusion of early endosomes [ 111. In this case, the GDP-bound form inhibits fusion it? a'ittn and in e i 7 . 0 , in contrast with the GTP-bound form, which promotes fusion. Even Rab3b, which is closely related to Rab3a, appears to be a positive modulator of prolactin secretion in pituitary cells Though the effects of the RabBaQ811, mutant are well established in different systems, the validity of the approach has to be discussed. This approach, based on the search for t r a mdominant mutants, has been used in many systems with various Rab proteins [Z] . I t assunies that the mutated protein participates in the physiological cycle of the natural protein, although the latter is still present in the cell. A difficulty might arise from the fact that the overexpressed mutant protein might titrate partners of the endogenous protein and might then inhibit its function without participating in the physiological cycle. I n this case, the inhibitory effect of the Rab3aQ81L mutant would rather indicate that the activity of endogenous Rab3a is to promote the secretory activity. In fact, the effects of a 1nh3u null mutation in mice have been interpreted in this way [13] . In these mice, most of the electrophysiological synaptic parameters were unchanged. From these results, Rab3a would appear to be dispensable for secretory vesicle exocytosis. However, analysis of excitatory postsynaptic currents in pyramidal cells from the hippocampus indicated a slight depression of the response after repetitive stimulation at moderate frequencies. This difference was attributed to a defect in the recruitment of readily releasable vesicles, leading to the conclusion that Rab3a was modulating positively this step.
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If Rab3aQ81L were acting by sequestering a
Rab3a partner, what could be the nature of this essential cofactor? Overexpression of Rab6N 1261, which affects intraGolgi transport, has no effect on exocytosis in PC12 cells [9] ; on the other hand, overexpression of wild-type Rab3a or of Rab3aN 1351 did not inhibit endoplasmic reticulum-to-Golgi transport [ 141. These results point towards a specific effect of Rab mutants on one step of intracellular traffic and argue against the titration by Rab3aQ81L of a factor common to the whole family of Rab proteins, such as geranylgeranyl transferase I1 or RabGDI. In addition, this component would have no affinity for the GDP-bound form, since the mutant Rab3aT36N, which has no affinity for GTP, has no inhibitory effect on exocytosis. This observation rules out guanine-nucleotide-releasing factor and RabGDI. If Rab3aQ81L were sequestering a Rab3-specific GAP, the endogenous Rab3a would thus stay longer in the GTP-bound form. Since the observed effect is an inhibition of the secretory activity, the conclusion would again be that G T P hydrolysis by Rab3a is rate limiting in the secretory process. We have recently found that the presence of the isoprenylation motif and of the C-terminal hypervariable domain, which is implicated in the targeting of Rab proteins to their specific compartment, is required for the activity of the GTPase-deficient Rab3 mutant in .4p/j-.via neurons (L. Johannes, F. Dousseau, J.-P. IIenry, F. Darchen and B. Poulain, unpublished work). 'Therefore this mutant must reach the synaptic vesicle membrane in order to affect exocytosis. Finally, the mutation V55E in the effector loop, which is supposed to block the interaction of Rab proteins with their effectors, suppresses the effect of Rab3aU81 L. This observation suggests that the factor which might be sequestered by exogenously added Rab3aQ8 1 L is the effector of Rab3a. However, to reach this effector and to sequester it, Rab3aQ81 L should be geranylgeranylated, associated with secretory vesicles, and bound to GTP. This is exactly what the endogenous Rab3a is supposed to do. Moreover, in :lp/j~sk neurons, the V55E mutation not only abolished the activity of recombinant Rab3 proteins, as expected if the latter were acting by sequestration of a cofactor, but also induced an enhancement of Ach release (L. Johannes, F. Dousseau, A. Clabecq, J.-P. Henry, F. Darchen and B. Poulain, unpublished work). For all these reasons, it seems very likely that the recombinant Rab3 protein enters the physiological cycle of the endogenous protein and can be taken as a good indicator of Rab3a function. In addition, the conclusion based on the effect of overexpression or microinjection of Rab3a mutants is fully consistent with the results obtained after antisense oligonucleotides injection into chromaffin cells Therefore we propose that G T P hydrolysis by Rab3a is rate limiting in exocytosis. This does not preclude the possibility that Rab3a might also have some positive effect on the secretory process. Recently, it has been proposed that Rabphilin-3a enhances secretion [ 151. This proposal was based on the stimulation of secretion that was observed after overexpression of Rabphilin-3A in chromaffin cells and on the inhibitory effect of antisense RNA. Rabphilin-3a is an 80 kDa protein expressed in brain and in chromaffin cells, which has a high affinity for Rab3a in its GTP-bound conformation. To account for the opposite effects of Rab3a and Rabphilin-3a, Chung et al. [15] proposed a sequential model in which GTP-bound Rab3a first associates with Rabphilin-3a; the latter protein would then promote exocytosis, probably through its C2 domains, which interact with phospholipids and Ca" ions. However, for this positive effect to occur, G T P hydrolysis would be required. This model is consistent with the results obtained with the knock-out of mb3a [13] and, especially, with the marked decrease of Rabphilin-3a in terminals of neurons expressing Rab3a. According to this model, Rab3a would have a dual effect on secretion. On one hand, it would be required to recruit Rabphilin-3a. On the other hand, Rab3a would add kinetic constraints due to its ratelimiting GTPase activity. These kinetic limitations might be different for other Rab3 isoforms or in different cell types, since the rate of G T P hydrolysis mainly depends upon the activity of cofactors such as GAP. 
Relationship between Rab3a and the receptor for soluble N-ethylmaleimidesensitive fusion protein attachment protein (SNARE) complex
When does Rab3a act in regulated exocytosis? At the present time, the data in the literature are confusing. Two major steps can be distinguished in the secretory process: (i) an ATP-dependent priming step, requiring low micromolar calcium concentration; and (ii) a rapid ATP-independent triggering step, requiring 10-100 pM CaZ+ con-centration. In chromaffin cells, Holz et al. [lo] pointed to a control of the triggering step by Rab3a, since overexpression of Rab3a affected mainly the initial rapid release. On the other hand, in Rab3a-deficient mice [13], a secretory defect appeared only after repeated stimulation, which was interpreted as a result of the exhaustion of a readily releasable pool of primed vesicles; this interpretation pointed to a function of Rab3a in the priming reaction.
In the literature there is no report describing a physical interaction between Rab3a and the components of the SNARE complex that would help to determine the step which is controlled by Rab3a. However, in yeast such interactions between other Rab proteins and the SNARE have been described by genetic and biochemical approaches. Overexpression of SEC9, a yeast homologue of the 2.5 kDa synaptosome-associated protein (SNAP-25), was found to suppress a mutation in the effector domain of SEC4 [16] . A mutation affecting the function of Yptl, which controls the endoplasmic-reticulum-to-Golgi transport, inhibited the assembly of the corresponding SNARE complex [ 17,181. Taken together, these observations suggested that Rab proteins might participate in and control the assembly of the SNARE complex.
Using the Aplysia neuronal system, we have recently obtained data supporting the existence of a relationship between Rab3a and the SNARE complex. Clostridial neurotoxins provoke a rapid and efficient inhibition of Ach release. However, when the neurons were first injected with the mutant protein Rab3aQ81L, which induced a 50% inhibition of Ach release, and then with tetanus toxin, the toxin-induced inhibition of Ach release was delayed for a long period of time, the latency being expressed in hours instead of minutes. The same protocol was repeated with botulinum A toxin, and again a very long delay was observed before the onset of toxin-induced inhibition of Ach release.
Since the vesicle-associated membrane protein (VAMP) and SNAP-2.5 are the targets of, respectively, tetanus and botulinum A neurotoxins, this observation suggests some relationship between Rab3a and the SNARE complex. The increased latency between toxin injection and Ach-release inhibition might indicate a limited access of clostridial toxins to their substrates in the presence of the Rab3aQ81L mutant, a mutant characterized by a rate-limiting hydrolysis of GTP. Interestingly, it has been shown that VAMP and SNAP-2.5 are protected from the proteolytic action of the toxins when they are engaged in the SNARE complex [19] . Therefore it might be proposed that the effect of the mutant Rab3aQ81L is to induce the accumulation of VAMP and SNAP-25 in the SNARE complex.
This accumulation of the SNARE complex might originate in an increased rate of assembly in the presence of the Rab3aQ81L mutant. However, it is difficult to reconcile an increase in formation of the SNARE complex with the inhibition of Ach release observed after injection of the mutant protein. Alternatively, the accumulation of the SNARE complex might result from a decrease of its consumption. According to this view, G T P hydrolysis by Rab3a would occur after the SNARE complex assembly. In the cell, the SNARE complex has been proposed to be associated with primed secretory vesicles, which are rapidly releasable [ZO] . Rab3a would thus control a late step in the secretory process, possibly at the end of the priming step or later. The inhibition of this step by a decreased rate of G T P hydrolysis would result in the accumulation of primed vesicles and, consequently, of toxinresistant SNARE.
